Imprimis NJOF, LLC recalls Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B,…
Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.
Read the official notice →- Date
- 2023-08-30
- Country
- United States
- Brand
- Imprimis NJOF
- Product
- Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B,…
- Classification
- Class III
- Units
- Nationwide in the US
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Imprimis NJOF recalls
- 2024-06-19
US- 2024-06-05
- US
- 2024-05-08
- US
- US
- 2023-10-25
- US
Imprimis NJOF, LLC recalls MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution Drops 1% - 0.5% - 2.5% - 0.5%, 5mL bottle,…
Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.
FDA · DrugImprimis NJOF, LLCProduct was distributed to physician's offices nationwide.Official notice → - 2023-10-11
- US
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC 71384-640-01 Not for resale.…
Subpotent: Failing Test Results for Epinephrine
Other drugs & medical recalls in the United States
- 2023-08-30
- US
Baxter Healthcare Corporation recalls Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare…
Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.
- US
Ecometics, Inc. recalls activator concentrate, Sodium Fluoride 0.96% in Activator Concentrate; 0.08% in diluted Activator Solution, Net 1 FL. OZ., Manufactured…
CGMP Deviations: Products not manufactured under current good manufacturing practices.
- US
Glenmark Pharmaceuticals Inc., USA recalls Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by:…
Subpotent: Out of Specification for Assay Test at the 3-month time point.
- US
Parker Laboratories, Inc. recalls Helix Pain Relieving Cream (Menthol 7.4%), packaged in a) 5 gm pouch (NDC 30775-051-01), b) 3 fl. oz. roll-on (NDC 30775-051-03), c) 4…
CGMP Deviations
FDA · DrugParker Laboratories, Inc.Nationwide within the United States, Singapore, Korea and Hong KongOfficial notice → - US
Aurobindo Pharma USA Inc. recalls Rufinamide Tablets, USP 400 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279…
cGMP deviations: Batch was released prior to approval.
- 2023-08-23
- US
Carefusion 2200 Inc recalls Snowden-Pencer MIS DIAMOND-TOUCH CLAMP BOWEL 50 MM JAW 5MM, 32CM, RATCHETED, REF SP90-7045; endoscopic surgical device
Specific lots of the product have the potential to exhibit cracking or breaking of the rotation knob due to the incorrect use of an adhesive in the manufacturing process.